The Flinn Foundation Seed Grants to Promote Translational Research Program opened the application for its next cycle of funding on Monday, Aug. 14, 2023. The deadline to apply is Monday, Oct. 2, 2023.Continue reading
Category Archives: AZBio News
C-Path Welcomes Sanofi to its Type 1 Diabetes Consortium to Help Advance Drug Development
The global immunology and diabetes leader will collaborate with C-Path’s T1DC to drive transformative change in type 1 diabetes prevention and treatment.Continue reading
C-Path’s Duchenne Regulatory Science Consortium and Duchenne Data Foundation Announce Collaboration to Advance Solutions for Duchenne Muscular Dystrophy
TUCSON, Ariz. and VEENENDAAL, Netherlands, August 9, 2023 — Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) and the Duchenne Data Foundation (DDF) are excited to announce a joint collaboration aimed at advancing research and improving healthcare for individuals with Duchenne muscular dystrophy (DMD) and other dystrophinopathies (conditions linked to mutations in the DMD gene).Continue reading
Mayo Clinic appoints Victor Ortega, M.D., associate director of Center for Individualized Medicine
PHOENIX, Ariz. — Victor Ortega, M.D., Ph.D., has been named associate director of Mayo
Clinic’s Center for Individualized Medicine in Arizona.Continue reading
Dr. David Alberts: A legacy of encouragement, innovation and scientific rigor
Dr. Alberts, who passed away on July 29 at the age of 83, not only assisted in creating the Arizona Cancer Center in 1976, but he also developed the center’s Cancer Prevention and Control Program into one of the top programs in the United States. He was honored with the inaugural AZBio Pioneer Award in 2012.
Mayo Clinic appoints Bhavik Patel, M.D., chief AI officer
PHOENIX, Ariz. — Bhavik Patel, M.D., has been appointed chief artificial intelligence (AI) officer for Mayo Clinic in Arizona. In this role, Dr. Patel will lead Mayo Clinic’s Advanced AI and Innovation Hub in Arizona with a focus on expanding AI-based solutions within Mayo’s three shields of Practice, Research and Education, in addition to business operations. Continue reading
Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow™ Mini Flusher Device for Hydrocephalus Patients
Intermountain Primary Children’s Hospital First in the Country to Implant this Next Generation FDA-Cleared Device
Company Welcomes Vice President of Sales & Marketing, Mark Geiger, Who Lives with HydrocephalusContinue reading
City of Hope scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research
The City of Hope-developed investigational small molecule selectively disrupts DNA replication and repair in cancer cells, leaving healthy cells unaffected, a new study reports.Continue reading
New UArizona study links brain waves directly to memory
The findings could lay foundations for cognitive impairment therapy and help improve memory.Continue reading
TGen appoints J. Gregory Caporaso, Ph.D., Professor in its Pathogen and Microbiome Division
Flagstaff, Arizona — July 25, 2023 — The Translational Genomics Research Institute (TGen), part of City of Hope, today announced that J. Gregory Caporaso, Ph.D., has joined the Institute as a Professor in its pathogen and microbiome division located in Flagstaff, more commonly known as TGen North. Continue reading